Delivery Order SPE2DB20D3303-SPE2DB24FA0ZJ
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,034.95 firm fixed price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $13,055.53 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide XIFAXAN 550 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a firm fixed price of $1,213.74 and a completion date of June 3, 2024. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This federal contract award to AmerisourceBergen Drug Corp, an established pharmaceutical distributor, provides for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription drug, to the U.S. government. The $5,177.09 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that procures medical supplies and equipment. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XIFAXAN 550 mg tablets over a period ending on September 23, 2024. The $40,062.50 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product XIFAXAN 550 mg tablets. The contract has a ceiling value of $82,211.95 and an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order against the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, valued at $11,837.36, is for the delivery of XIFAXAN 550 MG tablets to support federal healthcare programs. The contract has a period of performance through October 2024 and does not have a set-aside designation, indicating open competition. As a critical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of XIFAXAN 550 mg tablets to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $30,902.72 and an ultimate completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The $19,179.94 firm fixed-price delivery order has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order worth $11,191.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...